CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: all-trans-4-oxoretinoic acid
Accession: CHEBI:80656
browse the term
Definition: A retinoid that consists of all-trans-retinoic acid bearing an oxo substituent at position 4 on the cyclohexenyl ring.
Synonyms: exact_synonym: 4-oxoretinoic acid
related_synonym: 4-oxo-all-trans-retinoic acid; 4-oxo-atRA; Formula=C20H26O3; InChI=1S/C20H26O3/c1-14(7-6-8-15(2)13-19(22)23)9-10-17-16(3)18(21)11-12-20(17,4)5/h6-10,13H,11-12H2,1-5H3,(H,22,23)/b8-6+,10-9+,14-7+,15-13+; InChIKey=GGCUJPCCTQNTJF-FRCNGJHJSA-N; SMILES=C\\C(\\C=C\\C1=C(C)C(=O)CCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
xref: CAS:38030-57-8; HMDB:HMDB0006285; KEGG:C16678
xref_mesh: MESH:C002202
xref: PMID:2051220; PMID:25492813; PMID:2772923; PMID:435468; Reaxys:2878846
G
Aip
aryl-hydrocarbon receptor-interacting protein
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of AIP mRNA
CTD
PMID:15982314
NCBI chr19:4,163,756...4,177,233
Ensembl chr19:4,164,446...4,175,858
G
Anxa1
annexin A1
increases expression
ISO
4-oxoretinoic acid results in increased expression of ANXA1 mRNA
CTD
PMID:15982314
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Apod
apolipoprotein D
increases expression
ISO
4-oxoretinoic acid results in increased expression of APOD mRNA
CTD
PMID:15982314
NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626
G
Cbx3
chromobox 3
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of CBX3 mRNA
CTD
PMID:15982314
NCBI chr 6:51,447,596...51,460,684
Ensembl chr 6:51,447,340...51,460,684
G
Cdh1
cadherin 1
affects expression
ISO
4-oxoretinoic acid affects the expression of CDH1 mRNA
CTD
PMID:17034753
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Cdkn1c
cyclin dependent kinase inhibitor 1C
increases expression
ISO
4-oxoretinoic acid results in increased expression of CDKN1C mRNA
CTD
PMID:15982314
NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
G
Ckb
creatine kinase, brain
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of CKB mRNA
CTD
PMID:15982314
NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
G
Col1a1
collagen, type I, alpha 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of COL1A1 mRNA
CTD
PMID:17034753
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col4a2
collagen, type IV, alpha 2
increases expression
ISO
4-oxoretinoic acid results in increased expression of COL4A2 mRNA
CTD
PMID:17034753
NCBI chr 8:11,362,878...11,499,287
Ensembl chr 8:11,362,805...11,499,287
G
Col6a1
collagen, type VI, alpha 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of COL6A1 mRNA
CTD
PMID:15982314
NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002
G
Col8a2
collagen, type VIII, alpha 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of COL8A2 mRNA
CTD
PMID:15982314
NCBI chr 4:126,180,613...126,208,123
Ensembl chr 4:126,180,586...126,208,123
G
Crabp2
cellular retinoic acid binding protein II
increases expression
ISO
4-oxoretinoic acid results in increased expression of CRABP2 mRNA
CTD
PMID:17034753
NCBI chr 3:87,856,000...87,860,679
Ensembl chr 3:87,855,973...87,860,683
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of CXCL1 mRNA
CTD
PMID:15982314
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of CXCL1 mRNA
CTD
PMID:15982314
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases chemical synthesis
ISO
CYP1A1 protein results in increased chemical synthesis of 4-oxoretinoic acid
CTD
PMID:10874126
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
increases expression multiple interactions increases metabolic processing increases chemical synthesis
ISO
4-oxoretinoic acid results in increased expression of CYP26A1 mRNA [[Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-oxoretinoic acid; [[R 115866 results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-oxoretinoic acid; [Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased chemical synthesis of 4-oxoretinoic acid; [R 115866 results in decreased activity of CYP26A1 protein] which results in decreased chemical synthesis of 4-oxoretinoic acid; Ketoconazole inhibits the reaction [CYP26A1 mRNA results in increased chemical synthesis of 4-oxoretinoic acid]; Ketoconazole inhibits the reaction [CYP26A1 mRNA results in increased metabolism of 4-oxoretinoic acid] CYP26A1 mRNA results in increased metabolism of 4-oxoretinoic acid; CYP26A1 protein results in increased metabolism of 4-oxoretinoic acid CYP26A1 mRNA results in increased chemical synthesis of 4-oxoretinoic acid; CYP26A1 protein results in increased chemical synthesis of 4-oxoretinoic acid
CTD
PMID:12091498 PMID:17460545 PMID:25492813
NCBI chr19:37,686,186...37,689,984
Ensembl chr19:37,686,246...37,689,984
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of CYP27A1 mRNA
CTD
PMID:15982314
NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
G
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
increases chemical synthesis
ISO
CYP2C8 protein results in increased chemical synthesis of 4-oxoretinoic acid
CTD
PMID:10874126
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
increases chemical synthesis
ISO
CYP2C9 protein results in increased chemical synthesis of 4-oxoretinoic acid
CTD
PMID:10874126
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of CYP3A7 mRNA
CTD
PMID:15982314
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Dsc1
desmocollin 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of DSC1 mRNA
CTD
PMID:15982314
NCBI chr18:20,216,528...20,247,830
Ensembl chr18:20,217,241...20,247,928
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
4-oxoretinoic acid results in increased expression of DUSP10 mRNA
CTD
PMID:15982314
NCBI chr 1:183,766,575...183,807,833
Ensembl chr 1:183,745,499...183,807,833
G
Dusp11
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of DUSP11 mRNA
CTD
PMID:15982314
NCBI chr 6:85,919,250...85,938,950
Ensembl chr 6:85,919,250...85,938,649
G
E2f1
E2F transcription factor 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of E2F1 mRNA
CTD
PMID:15982314
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of EGFR mRNA
CTD
PMID:15982314
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of EIF4EBP2 mRNA
CTD
PMID:15982314
NCBI chr10:61,268,276...61,288,448
Ensembl chr10:61,264,270...61,288,440
G
Emp1
epithelial membrane protein 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of EMP1 mRNA
CTD
PMID:15982314
NCBI chr 6:135,339,548...135,360,171
Ensembl chr 6:135,339,543...135,360,171
G
Fabp5
fatty acid binding protein 5, epidermal
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of FABP5 mRNA
CTD
PMID:15982314
NCBI chr 3:10,077,645...10,081,670
Ensembl chr 3:10,077,608...10,081,667
G
Fam3c
FAM3 metabolism regulating signaling molecule C
increases expression
ISO
4-oxoretinoic acid results in increased expression of FAM3C mRNA
CTD
PMID:15982314
NCBI chr 6:22,306,519...22,356,080
Ensembl chr 6:22,306,519...22,356,242
G
Fas
Fas cell surface death receptor
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of FAS mRNA
CTD
PMID:17034753
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasn
fatty acid synthase
increases expression
ISO
4-oxoretinoic acid results in increased expression of FASN mRNA
CTD
PMID:15982314
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
G
Fastk
Fas-activated serine/threonine kinase
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of FASTK mRNA
CTD
PMID:15982314
NCBI chr 5:24,646,036...24,650,280
Ensembl chr 5:24,643,438...24,650,285
G
Fgf1
fibroblast growth factor 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of FGF1 mRNA
CTD
PMID:15982314
NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525
G
Fkbp8
FK506 binding protein 8
increases expression
ISO
4-oxoretinoic acid results in increased expression of FKBP8 mRNA
CTD
PMID:15982314
NCBI chr 8:70,980,371...70,987,978
Ensembl chr 8:70,980,374...70,987,978
G
Flg
filaggrin
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of FLG mRNA
CTD
PMID:15982314
NCBI chr 3:93,180,853...93,200,996
Ensembl chr 3:93,180,830...93,200,993
G
Foxa1
forkhead box A1
increases expression
ISO
4-oxoretinoic acid results in increased expression of FOXA1 mRNA
CTD
PMID:17034753
NCBI chr12:57,585,750...57,594,815
Ensembl chr12:57,587,414...57,593,702
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
increases expression
ISO
4-oxoretinoic acid results in increased expression of G6PD mRNA
CTD
PMID:15982314
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gata6
GATA binding protein 6
increases expression
ISO
4-oxoretinoic acid results in increased expression of GATA6 mRNA
CTD
PMID:17034753
NCBI chr18:11,052,510...11,085,636
Ensembl chr18:11,052,064...11,085,635
G
Gba1
glucosylceramidase beta 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of GBA1 mRNA
CTD
PMID:15982314
NCBI chr 3:89,110,235...89,119,944
Ensembl chr 3:89,110,235...89,116,273
G
Gdf15
growth differentiation factor 15
increases expression
ISO
4-oxoretinoic acid results in increased expression of GDF15 mRNA
CTD
PMID:15982314
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
G
Gdf2
growth differentiation factor 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of GDF2 mRNA
CTD
PMID:15982314
NCBI chr14:33,662,996...33,669,155
Ensembl chr14:33,662,996...33,669,155
G
Glul
glutamate-ammonia ligase
increases expression
ISO
4-oxoretinoic acid results in increased expression of GLUL mRNA
CTD
PMID:15982314
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Grb7
growth factor receptor bound protein 7
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of GRB7 mRNA
CTD
PMID:15982314
NCBI chr11:98,337,660...98,346,199
Ensembl chr11:98,337,220...98,346,199
G
Gstm1
glutathione S-transferase, mu 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of GSTM1 mRNA
CTD
PMID:15982314
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
4-oxoretinoic acid results in increased expression of HBEGF mRNA
CTD
PMID:15982314
NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
G
Igf1
insulin-like growth factor 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of IGF1 mRNA
CTD
PMID:15982314
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf2
insulin-like growth factor 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of IGF2 mRNA
CTD
PMID:15982314
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Igfbp3
insulin-like growth factor binding protein 3
increases expression
ISO
4-oxoretinoic acid results in increased expression of IGFBP3 mRNA
CTD
PMID:15982314
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Il10ra
interleukin 10 receptor, alpha
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of IL10RA mRNA
CTD
PMID:15982314
NCBI chr 9:45,165,135...45,180,447
Ensembl chr 9:45,165,135...45,180,447
G
Il1b
interleukin 1 beta
increases expression
ISO
4-oxoretinoic acid results in increased expression of IL1B mRNA
CTD
PMID:15982314
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il24
interleukin 24
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of IL24 mRNA
CTD
PMID:15982314
NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191
G
Itga4
integrin alpha 4
increases expression
ISO
4-oxoretinoic acid results in increased expression of ITGA4 mRNA
CTD
PMID:15982314
NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467
G
Ivl
involucrin
increases expression
ISO
4-oxoretinoic acid results in increased expression of IVL mRNA
CTD
PMID:17034753
NCBI chr 3:92,478,206...92,481,097
Ensembl chr 3:92,478,209...92,481,042
G
Krt1
keratin 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of KRT1 mRNA
CTD
PMID:15982314
NCBI chr15:101,753,861...101,759,221
Ensembl chr15:101,753,861...101,759,229
G
Krt10
keratin 10
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of KRT10 mRNA
CTD
PMID:15982314
NCBI chr11:99,276,080...99,288,631
Ensembl chr11:99,276,080...99,280,190
G
Krt14
keratin 14
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of KRT14 mRNA
CTD
PMID:15982314
NCBI chr11:100,093,988...100,098,336
Ensembl chr11:100,093,988...100,098,374
G
Krt15
keratin 15
increases expression
ISO
4-oxoretinoic acid results in increased expression of KRT15 mRNA
CTD
PMID:15982314
NCBI chr11:100,022,585...100,026,775
Ensembl chr11:100,022,584...100,026,754
G
Krt17
keratin 17
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of KRT17 mRNA
CTD
PMID:15982314
NCBI chr11:100,147,041...100,151,855
Ensembl chr11:100,147,043...100,151,855
G
Krt18
keratin 18
increases expression
ISO
4-oxoretinoic acid results in increased expression of KRT18 mRNA
CTD
PMID:17034753
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Krt19
keratin 19
increases expression
ISO
4-oxoretinoic acid results in increased expression of KRT19 mRNA; 4-oxoretinoic acid results in increased expression of KRT19 protein
CTD
PMID:15982314 PMID:17034753
NCBI chr11:100,031,636...100,036,752
Ensembl chr11:100,031,636...100,039,491
G
Krt5
keratin 5
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of KRT5 mRNA
CTD
PMID:15982314
NCBI chr15:101,615,504...101,621,340
Ensembl chr15:101,615,505...101,621,333
G
Krt6a
keratin 6A
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of KRT6A mRNA
CTD
PMID:15982314
NCBI chr15:101,598,363...101,602,746
Ensembl chr15:101,598,345...101,602,742
G
Krt7
keratin 7
increases expression
ISO
4-oxoretinoic acid results in increased expression of KRT7 mRNA; 4-oxoretinoic acid results in increased expression of KRT7 protein
CTD
PMID:15982314 PMID:17034753
NCBI chr15:101,310,284...101,325,687
Ensembl chr15:101,308,924...101,328,194
G
Krt75
keratin 75
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of KRT75 mRNA
CTD
PMID:15982314
NCBI chr15:101,471,778...101,482,339
Ensembl chr15:101,471,780...101,482,339
G
Krt8
keratin 8
increases expression
ISO
4-oxoretinoic acid results in increased expression of KRT8 mRNA
CTD
PMID:17034753
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Lama2
laminin, alpha 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of LAMA2 mRNA
CTD
PMID:15982314
NCBI chr10:26,857,281...27,493,021
Ensembl chr10:26,856,032...27,495,754
G
Lama3
laminin, alpha 3
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of LAMA3 mRNA
CTD
PMID:15982314
NCBI chr18:12,466,806...12,716,070
Ensembl chr18:12,466,876...12,716,070
G
Lamc3
laminin gamma 3
increases expression
ISO
4-oxoretinoic acid results in increased expression of LAMC3 mRNA
CTD
PMID:15982314
NCBI chr 2:31,777,293...31,839,095
Ensembl chr 2:31,777,303...31,836,551
G
Lcn2
lipocalin 2
increases expression
ISO
4-oxoretinoic acid results in increased expression of LCN2 mRNA
CTD
PMID:15982314
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Mcl1
myeloid cell leukemia sequence 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of MCL1 mRNA
CTD
PMID:17034753
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
G
Meis1
Meis homeobox 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of MEIS1 mRNA
CTD
PMID:17034753
NCBI chr11:18,830,428...18,968,992
Ensembl chr11:18,829,817...18,968,985
G
Meis2
Meis homeobox 2
increases expression
ISO
4-oxoretinoic acid results in increased expression of MEIS2 mRNA
CTD
PMID:17034753
NCBI chr 2:115,691,745...115,897,925
Ensembl chr 2:115,693,545...115,896,320
G
Meox1
mesenchyme homeobox 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of MEOX1 mRNA
CTD
PMID:17034753
NCBI chr11:101,768,336...101,785,309
Ensembl chr11:101,768,336...101,785,200
G
Mfap2
microfibrillar-associated protein 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of MFAP2 mRNA
CTD
PMID:15982314
NCBI chr 4:140,737,735...140,743,284
Ensembl chr 4:140,737,729...140,743,295
G
Mmp10
matrix metallopeptidase 10
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of MMP10 mRNA
CTD
PMID:15982314
NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
increases expression
ISO
4-oxoretinoic acid results in increased expression of MUC5AC mRNA
CTD
PMID:17034753
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Nedd9
neural precursor cell expressed, developmentally down-regulated gene 9
increases expression
ISO
4-oxoretinoic acid results in increased expression of NEDD9 mRNA
CTD
PMID:15982314
NCBI chr13:41,463,392...41,640,836
Ensembl chr13:41,463,057...41,640,838
G
Nefl
neurofilament, light polypeptide
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of NEFL mRNA
CTD
PMID:15982314
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
Odc1
ornithine decarboxylase, structural 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of ODC1 mRNA
CTD
PMID:15982314
NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506
G
Olr1
oxidized low density lipoprotein (lectin-like) receptor 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of OLR1 mRNA
CTD
PMID:17034753
NCBI chr 6:129,456,113...129,484,312
Ensembl chr 6:129,462,207...129,484,128
G
Pir
pirin
increases expression
ISO
4-oxoretinoic acid results in increased expression of PIR mRNA
CTD
PMID:15982314
NCBI chr X:163,052,427...163,156,009
Ensembl chr X:163,052,367...163,156,007
G
Plat
plasminogen activator, tissue
increases expression
ISO
4-oxoretinoic acid results in increased expression of PLAT mRNA
CTD
PMID:15982314
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of PTGS1 mRNA
CTD
PMID:15982314
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of PTGS2 mRNA
CTD
PMID:15982314
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rara
retinoic acid receptor, alpha
increases expression increases activity
ISO
4-oxoretinoic acid results in increased expression of RARA mRNA 4-oxoretinoic acid results in increased activity of RARA protein
CTD
PMID:17034753 PMID:25492813
NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
G
Rarb
retinoic acid receptor, beta
increases activity increases expression
ISO
4-oxoretinoic acid results in increased activity of RARB protein 4-oxoretinoic acid results in increased expression of RARB mRNA
CTD
PMID:17034753 PMID:25492813
NCBI chr14:5,387,365...6,038,924
Ensembl chr14:5,650,540...6,038,924
G
Rarg
retinoic acid receptor, gamma
increases activity multiple interactions
ISO
4-oxoretinoic acid results in increased activity of RARG protein 4-oxoretinoic acid results in increased activity of [RARG protein binds to RXRA protein]
CTD
PMID:25492813 PMID:30639747
NCBI chr15:102,143,373...102,165,891
Ensembl chr15:102,143,373...102,165,952
G
Rarres1
retinoic acid receptor responder (tazarotene induced) 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of RARRES1 mRNA
CTD
PMID:17034753
NCBI chr 3:67,386,219...67,422,856
Ensembl chr 3:67,386,305...67,422,856
G
Rhoa
ras homolog family member A
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of RHOA mRNA
CTD
PMID:15982314
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Rhob
ras homolog family member B
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of RHOB mRNA
CTD
PMID:15982314
NCBI chr12:8,547,661...8,550,009
Ensembl chr12:8,547,661...8,550,009
G
Rnf5
ring finger protein 5
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of RNF5 mRNA
CTD
PMID:15982314
NCBI chr17:34,820,073...34,822,535
Ensembl chr17:34,820,065...34,822,664
G
Rps13
ribosomal protein S13
increases expression
ISO
4-oxoretinoic acid results in increased expression of RPS13 mRNA
CTD
PMID:15982314
NCBI chr 7:115,930,742...115,933,425
Ensembl chr 7:115,930,740...115,933,430
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
4-oxoretinoic acid results in increased activity of [RARG protein binds to RXRA protein]
CTD
PMID:30639747
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
S100a1
S100 calcium binding protein A1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of S100A1 mRNA
CTD
PMID:15982314
NCBI chr 3:90,418,341...90,421,637
Ensembl chr 3:90,418,341...90,421,699
G
S100a8
S100 calcium binding protein A8 (calgranulin A)
increases expression
ISO
4-oxoretinoic acid results in increased expression of S100A8 mRNA
CTD
PMID:15982314
NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
G
S100a9
S100 calcium binding protein A9 (calgranulin B)
increases expression
ISO
4-oxoretinoic acid results in increased expression of S100A9 mRNA
CTD
PMID:15982314
NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
G
Serpina3b
serine (or cysteine) peptidase inhibitor, clade A, member 3B
increases expression
ISO
4-oxoretinoic acid results in increased expression of SERPINA3 mRNA
CTD
PMID:15982314
NCBI chr12:104,094,245...104,105,805
Ensembl chr12:104,094,255...104,105,804
G
Serpinb2
serine (or cysteine) peptidase inhibitor, clade B, member 2
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of SERPINB2 mRNA
CTD
PMID:15982314
NCBI chr 1:107,439,153...107,453,330
Ensembl chr 1:107,439,153...107,463,208
G
Serpinb9
serine (or cysteine) peptidase inhibitor, clade B, member 9
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of SERPINB9 mRNA
CTD
PMID:15982314
NCBI chr13:33,181,044...33,201,938
Ensembl chr13:33,187,233...33,201,940
G
Slc16a1
solute carrier family 16 (monocarboxylic acid transporters), member 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of SLC16A1 mRNA
CTD
PMID:15982314
NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778
G
Socs1
suppressor of cytokine signaling 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of SOCS1 mRNA
CTD
PMID:15982314
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Socs2
suppressor of cytokine signaling 2
increases expression
ISO
4-oxoretinoic acid results in increased expression of SOCS2 mRNA
CTD
PMID:15982314
NCBI chr10:95,219,765...95,253,176
Ensembl chr10:95,221,224...95,253,042
G
Sprr1b
small proline-rich protein 1B
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of SPRR1B mRNA
CTD
PMID:15982314
NCBI chr 3:92,344,115...92,346,124
Ensembl chr 3:92,344,116...92,346,096
G
Sult2a1
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of SULT2A1 mRNA
CTD
PMID:15982314
NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
increases expression
ISO
4-oxoretinoic acid results in increased expression of TGFB1I1 mRNA
CTD
PMID:15982314
NCBI chr 7:127,845,963...127,852,884
Ensembl chr 7:127,845,984...127,854,871
G
Tgm1
transglutaminase 1, K polypeptide
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of TGM1 mRNA
CTD
PMID:15982314
NCBI chr14:55,937,466...55,951,378
Ensembl chr14:55,937,466...55,951,383
G
Tgm2
transglutaminase 2, C polypeptide
increases expression
ISO
4-oxoretinoic acid results in increased expression of TGM2 mRNA
CTD
PMID:17034753
NCBI chr 2:157,958,325...157,988,312
Ensembl chr 2:157,958,322...157,988,356
G
Thbs1
thrombospondin 1
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of THBS1 mRNA
CTD
PMID:15982314
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Tmsb4x
thymosin, beta 4, X chromosome
increases expression
ISO
4-oxoretinoic acid results in increased expression of TMSB4X mRNA
CTD
PMID:15982314
NCBI chr X:165,990,089...165,996,475
Ensembl chr X:165,990,089...165,992,311
G
Vegfc
vascular endothelial growth factor C
decreases expression
ISO
4-oxoretinoic acid results in decreased expression of VEGFC mRNA
CTD
PMID:15982314
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all